Citadel Advisors’s ASP Isotopes ASPI Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPI
ECA
RIM
ETC
AIC
Citadel Advisors's ASPI Position: Q2 2026 in Review
Citadel Advisors reduced its ASP Isotopes (ASPI) stake by 53% in Q2 2026, selling an estimated $2.42M and leaving 357,591 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #6317.
Citadel Advisors first reported a position in ASPI in Q4 2023 and has held it in 7 quarters since. The position peaked at $11.2M in Q3 2025. 185 funds tracked by Wall St. Rank hold ASPI as of Q2 2026.
- Citadel Advisors held 357,591 shares of ASP Isotopes worth $2.22M as of Q2 2026.
- Citadel Advisors sold 410,415 ASP Isotopes shares in Q2 2026, an estimated $2.42M.
- ASP Isotopes made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #6317 holding.
- Citadel Advisors first reported a position in ASP Isotopes in Q4 2023 and has held it in 7 quarters since.
- Citadel Advisors's ASP Isotopes position peaked at $11.2M in Q3 2025.
- 185 funds tracked by Wall St. Rank held ASP Isotopes as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.